NKTR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.71%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $377,218.13

Nektar Therapeutics Insider Trading History Chart

Nektar Therapeutics Share Price & Price History

^$0.74

▼ -0.0151 (-2.00%)

As of 04/29/2025 05:00 PM ET

Days: 30 | 90 | 365

Nektar Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/19/2025	Howard W Robin	CEO	Sell	23,774	$1.01	$24,011.74	1,086,901
2/19/2025	Jonathan Zalevsky	Insider	Sell	10,300	$1.01	$10,403.00	316,604
12/23/2024	Mark Andrew Wilson	Insider	Sell	33,402	$0.90	$30,061.80	351,892
12/19/2024	Jonathan Zalevsky	Insider	Sell	51,115	$0.94	$48,048.10	326,904
12/17/2024	Howard W Robin	CEO	Sell	46,995	$1.01	$47,464.95	1,195,710
11/19/2024	Howard W Robin	CEO	Sell	16,278	$1.01	$16,440.78	832,080
11/19/2024	Jonathan Zalevsky	Insider	Sell	7,785	$1.01	$7,862.85	243,019
8/19/2024	Howard W Robin	CEO	Sell	14,881	$1.28	$19,047.68	848,358
8/19/2024	Jonathan Zalevsky	Insider	Sell	6,866	$1.28	$8,788.48	250,804
6/14/2024	Robert Chess	Director	Sell	19,500	$1.20	$23,400.00	255,273
5/17/2024	Howard W Robin	CEO	Sell	16,650	$1.75	$29,137.50	863,239
5/17/2024	Jonathan Zalevsky	Insider	Sell	7,355	$1.75	$12,871.25	257,670
5/10/2024	Deep Track Capital, Lp	Major Shareholder	Sell	56,000	$1.78	$99,680.00	18,344,000
2/20/2024	Howard W Robin	CEO	Sell	20,033	$0.68	$13,622.44	879,889
2/20/2024	Jonathan Zalevsky	Insider	Sell	9,014	$0.68	$6,129.52	265,025
11/17/2023	Howard W Robin	CEO	Sell	19,877	$0.49	$9,739.73	899,922
11/17/2023	Jonathan Zalevsky	Insider	Sell	9,646	$0.49	$4,726.54	274,039
9/18/2023	Myriam Curet	Director	Sell	4,359	$0.69	$3,007.71	27,418
8/16/2023	Howard W Robin	CEO	Sell	19,998	$0.78	$15,598.44	919,799
8/16/2023	Jonathan Zalevsky	Insider	Sell	9,703	$0.78	$7,568.34	283,685
6/14/2023	Roy A Whitfield	Director	Sell	30,000	$0.57	$17,100.00	216,250
5/16/2023	Howard W Robin	CEO	Sell	20,361	$0.72	$14,659.92	939,797
5/16/2023	Jonathan Zalevsky	Insider	Sell	9,791	$0.72	$7,049.52	293,388
2/16/2023	Howard W Robin	CEO	Sell	19,635	$3.00	$58,905.00	960,158
2/16/2023	Jillian B. Thomsen	CFO	Sell	10,267	$3.00	$30,801.00	313,497
2/16/2023	Jonathan Zalevsky	Insider	Sell	10,484	$3.00	$31,452.00	303,179
11/16/2022	Howard W Robin	CEO	Sell	38,014	$3.57	$135,709.98	979,793
11/16/2022	Jillian B. Thomsen	CFO	Sell	11,095	$3.57	$39,609.15	323,764
11/16/2022	Jonathan Zalevsky	Insider	Sell	13,460	$3.57	$48,052.20	313,663
9/23/2022	Myriam Curet	Director	Sell	4,198	$3.16	$13,265.68	31,777
9/13/2022	Karin Eastham	Director	Sell	21,267	$3.61	$76,773.87	13,033
8/18/2022	Jonathan Zalevsky	Insider	Sell	73,716	$4.65	$342,779.40	327,123
8/16/2022	Howard W Robin	CEO	Sell	13,759	$4.76	$65,492.84	1,017,807
8/16/2022	Jillian B. Thomsen	CAO	Sell	2,006	$4.76	$9,548.56	334,859
8/16/2022	Jonathan Zalevsky	Insider	Sell	10,560	$4.76	$50,265.60	400,839
8/16/2022	Mark Andrew Wilson	SVP	Sell	3,189	$4.76	$15,179.64	281,188
5/16/2022	Gil M. Labrucherie	CFO	Sell	17,448	$3.95	$68,919.60	312,905
5/16/2022	Howard W Robin	CEO	Sell	36,529	$3.95	$144,289.55	620,941
5/16/2022	Jillian B. Thomsen	CAO	Sell	5,841	$3.95	$23,071.95	170,427
5/16/2022	Jonathan Zalevsky	Insider	Sell	21,673	$3.95	$85,608.35	276,399
5/16/2022	Mark Andrew Wilson	SVP	Sell	3,136	$3.95	$12,387.20	117,939

See Full Table

SEC Filings (Institutional Ownership Changes) for Nektar Therapeutics (NASDAQ:NKTR)

75.88% of Nektar Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nektar Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/29/2025	Bank of New York Mellon Corp	393,293	$0.27M	0.0%	-4.1%	0.211%
4/16/2025	Wealth Enhancement Advisory Services LLC	60,371	$41K	0.0%	N/A	0.032%
4/8/2025	Rhumbline Advisers	221,761	$0.15M	0.0%	+23.3%	0.119%
3/24/2025	Wellington Management Group LLP	522,409	$0.49M	0.0%	+10.4%	0.281%
2/20/2025	Mackenzie Financial Corp	469,769	$0.44M	0.0%	+801.4%	0.255%
2/19/2025	Public Employees Retirement System of Ohio	142,064	$0.13M	0.0%	-10.7%	0.077%
2/18/2025	US Asset Management LLC	33,484	$31K	0.0%	N/A	0.018%
2/17/2025	Woodline Partners LP	4,974,512	$4.63M	0.0%	+187.3%	2.697%
2/17/2025	Squarepoint Ops LLC	139,758	$0.13M	0.0%	N/A	0.076%
2/17/2025	Two Sigma Advisers LP	1,486,242	$1.38M	0.0%	-0.9%	0.806%
2/17/2025	Two Sigma Investments LP	1,537,355	$1.43M	0.0%	+12.8%	0.833%
2/17/2025	Shay Capital LLC	352,204	$0.33M	0.0%	-77.9%	0.191%
2/17/2025	ProShare Advisors LLC	50,277	$47K	0.0%	+49.0%	0.027%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,580,916	$1.47M	0.1%	+37.4%	0.857%
2/17/2025	Millennium Management LLC	4,524,946	$4.21M	0.0%	-10.6%	2.453%
2/17/2025	Jacobs Levy Equity Management Inc.	2,626,961	$2.44M	0.0%	-6.0%	1.424%
2/17/2025	Graham Capital Management L.P.	96,911	$90K	0.0%	+408.5%	0.053%
2/17/2025	D. E. Shaw & Co. Inc.	175,193	$0.16M	0.0%	+267.0%	0.095%
2/17/2025	Deep Track Capital LP	1,975,998	$1.84M	0.1%	-87.6%	1.071%
2/17/2025	Bridgeway Capital Management LLC	1,292,100	$1.20M	0.0%	-5.1%	0.700%
2/17/2025	Bank of America Corp DE	207,267	$0.19M	0.0%	-5.0%	0.112%
2/17/2025	BNP Paribas Financial Markets	312,693	$0.29M	0.0%	+30.9%	0.170%
2/17/2025	Ameriprise Financial Inc.	373,948	$0.35M	0.0%	+32.8%	0.203%
2/17/2025	22NW LP	2,191,750	$2.04M	1.5%	N/A	1.188%
2/14/2025	Nantahala Capital Management LLC	7,810,000	$7.26M	0.3%	+90.0%	4.234%
2/14/2025	Northern Trust Corp	1,414,984	$1.32M	0.0%	+0.9%	0.767%
2/14/2025	Boothbay Fund Management LLC	555,876	$0.52M	0.0%	+59.3%	0.301%
2/14/2025	Two Sigma Securities LLC	27,654	$26K	0.0%	+56.3%	0.015%
2/14/2025	Voya Investment Management LLC	181,679	$0.17M	0.0%	+200.3%	0.098%
2/14/2025	Price T Rowe Associates Inc. MD	192,978	$0.18M	0.0%	+6.0%	0.105%
2/14/2025	Harvest Investment Services LLC	29,244	$27K	0.0%	N/A	0.016%
2/14/2025	Diadema Partners LP	698,919	$0.65M	0.3%	N/A	0.379%
2/14/2025	Altium Capital Management LLC	3,000,000	$2.79M	0.8%	+26,172.0%	1.626%
2/13/2025	XTX Topco Ltd	244,701	$0.23M	0.0%	+595.8%	0.133%
2/13/2025	Barclays PLC	325,818	$0.30M	0.0%	-9.1%	0.177%
2/13/2025	Renaissance Technologies LLC	3,910,786	$3.64M	0.0%	+17.5%	2.120%
2/13/2025	Russell Investments Group Ltd.	67,829	$63K	0.0%	-24.2%	0.037%
2/13/2025	Wells Fargo & Company MN	108,975	$0.10M	0.0%	+26.5%	0.059%
2/12/2025	Wellington Management Group LLP	522,409	$0.49M	0.0%	+10.4%	0.283%
2/12/2025	JPMorgan Chase & Co.	1,182,995	$1.10M	0.0%	+29.5%	0.641%
2/11/2025	Sei Investments Co.	94,152	$88K	0.0%	+50.6%	0.051%
2/10/2025	Primecap Management Co. CA	5,540,386	$5.15M	0.0%	-6.3%	3.004%
2/10/2025	Monaco Asset Management SAM	2,032,868	$1.89M	0.3%	+1.8%	1.102%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	730,875	$0.68M	0.0%	+12.3%	0.396%
1/29/2025	Peapod Lane Capital LLC	1,107,516	$1.03M	1.0%	N/A	0.600%
1/28/2025	Moloney Securities Asset Management LLC	50,000	$46K	0.0%	+42.4%	0.027%
1/17/2025	SG Americas Securities LLC	107,318	$100K	0.0%	+12.2%	0.058%
1/15/2025	HB Wealth Management LLC	64,100	$60K	0.0%	+44.0%	0.035%
12/26/2024	JPMorgan Chase & Co.	913,300	$1.19M	0.0%	+197.3%	0.495%
11/19/2024	Barclays PLC	358,294	$0.47M	0.0%	+96.1%	0.194%
11/16/2024	Geode Capital Management LLC	3,963,083	$5.15M	0.0%	-3.6%	2.149%
11/15/2024	Barclays PLC	358,294	$0.47M	0.0%	+96.1%	0.194%
11/15/2024	XTX Topco Ltd	35,170	$46K	0.0%	N/A	0.019%
11/15/2024	Jane Street Group LLC	91,470	$0.12M	0.0%	+50.0%	0.050%
11/15/2024	Wellington Management Group LLP	473,090	$0.62M	0.0%	N/A	0.256%
11/15/2024	State Street Corp	3,345,733	$4.35M	0.0%	+11.9%	1.814%
11/15/2024	Jacobs Levy Equity Management Inc.	2,793,204	$3.63M	0.0%	-2.8%	1.514%
11/15/2024	Erste Asset Management GmbH	46,800	$61K	0.0%	N/A	0.025%
11/14/2024	Eventide Asset Management LLC	9,400,000	$12.22M	0.2%	+24.8%	5.096%
11/14/2024	MetLife Investment Management LLC	106,506	$0.14M	0.0%	+129.1%	0.058%
11/13/2024	BNP Paribas Financial Markets	238,846	$0.31M	0.0%	+1,877.2%	0.129%
11/13/2024	FMR LLC	386,656	$0.50M	0.0%	+403.2%	0.210%
11/13/2024	The Manufacturers Life Insurance Company	66,218	$86K	0.0%	N/A	0.036%
11/12/2024	Valence8 US LP	26,107	$34K	0.0%	N/A	0.014%
11/12/2024	Charles Schwab Investment Management Inc.	1,454,168	$1.89M	0.0%	-2.3%	0.790%
11/9/2024	Primecap Management Co. CA	5,912,453	$7.69M	0.0%	-1.8%	3.212%
11/9/2024	Intech Investment Management LLC	31,249	$41K	0.0%	N/A	0.017%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	650,841	$0.85M	0.0%	+5.6%	0.354%
11/5/2024	GSA Capital Partners LLP	214,245	$0.28M	0.0%	-77.0%	0.116%
10/30/2024	Moloney Securities Asset Management LLC	35,105	$46K	0.0%	-58.8%	0.019%
10/3/2024	SG Americas Securities LLC	95,637	$0.12M	0.0%	+30.4%	0.052%
8/20/2024	Nantahala Capital Management LLC	4,110,000	$5.10M	0.3%	+66.0%	2.233%
8/15/2024	Mackenzie Financial Corp	43,765	$54K	0.0%	-54.9%	0.024%
8/15/2024	Millennium Management LLC	4,659,469	$5.78M	0.0%	+56.1%	2.532%
8/15/2024	Armistice Capital LLC	836,000	$1.04M	0.0%	N/A	0.454%
8/14/2024	Samlyn Capital LLC	9,457,887	$11.73M	0.2%	N/A	5.140%
8/9/2024	Primecap Management Co. CA	6,020,453	$7.47M	0.0%	-13.6%	3.272%
8/9/2024	Renaissance Technologies LLC	3,313,833	$4.11M	0.0%	-28.3%	1.801%
8/9/2024	Dimensional Fund Advisors LP	515,998	$0.64M	0.0%	-5.1%	0.280%
8/7/2024	Monaco Asset Management SAM	2,166,432	$2.69M	0.4%	-62.8%	1.177%
8/6/2024	Acadian Asset Management LLC	4,884,594	$6.06M	0.0%	-35.5%	2.654%
8/6/2024	Candriam S.C.A.	79,594	$99K	0.0%	N/A	0.043%
8/5/2024	Acuitas Investments LLC	879,904	$1.09M	0.6%	-31.3%	0.478%
8/5/2024	Victory Capital Management Inc.	23,031	$29K	0.0%	N/A	0.013%
8/2/2024	CM Management LLC	750,000	$0.93M	0.8%	-20.2%	0.408%
8/1/2024	Rhumbline Advisers	185,116	$0.23M	0.0%	+3,377.0%	0.101%
7/30/2024	Moloney Securities Asset Management LLC	85,105	$0.11M	0.0%	-19.0%	0.046%
7/26/2024	Bank of New York Mellon Corp	551,535	$0.68M	0.0%	+2,822.5%	0.300%
7/19/2024	Values First Advisors Inc.	45,197	$56K	0.0%	N/A	0.025%
7/12/2024	SG Americas Securities LLC	73,352	$91K	0.0%	+63.0%	0.040%
5/30/2024	Lynx1 Capital Management LP	2,068,842	$1.93M	0.5%	+7.2%	1.127%
5/16/2024	Jacobs Levy Equity Management Inc.	1,911,186	$1.79M	0.0%	-43.9%	1.041%
5/15/2024	Public Employees Retirement System of Ohio	169,749	$0.16M	0.0%	-38.3%	0.092%
5/10/2024	Acadian Asset Management LLC	7,569,063	$7.07M	0.0%	-3.2%	4.122%
5/10/2024	Vanguard Group Inc.	12,049,138	$11.26M	0.0%	+0.1%	6.562%
5/9/2024	Monaco Asset Management SAM	5,831,565	$5.45M	1.6%	-2.4%	3.176%
5/9/2024	State Board of Administration of Florida Retirement System	67,437	$63K	0.0%	N/A	0.037%
5/8/2024	Russell Investments Group Ltd.	82,434	$77K	0.0%	-26.9%	0.045%
5/7/2024	SG Americas Securities LLC	45,014	$42K	0.0%	-55.7%	0.025%
5/7/2024	Marquette Asset Management LLC	232,289	$0.22M	0.0%	+24.8%	0.127%

Data available starting January 2016

See Full Table

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 2b clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1 clinical trial to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.

Today's Range

Now: $0.74

$0.72

$0.77

50 Day Range

MA: $0.74

$0.49

$0.96

52 Week Range

Now: $0.74

$0.43

$1.93

Volume

950,548 shs

Average Volume

1,813,592 shs

Market Capitalization

$137.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Nektar Therapeutics?: Nektar Therapeutics' top insider investors include:
Deep Track Capital, Lp (Major Shareholder)
Howard W Robin (CEO)
Mark Andrew Wilson (Insider)
Jonathan Zalevsky (Insider)
Robert Chess (Director)
Roy A Whitfield (Director)
Myriam Curet (Director)
Learn More about top insider investors at Nektar Therapeutics.
Who are the major institutional investors of Nektar Therapeutics?: Nektar Therapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.12%
Wealth Enhancement Advisory Services LLC — 0.03%
Learn More about top institutional investors of Nektar Therapeutics stock.
Which major investors are buying Nektar Therapeutics stock?: Within the last quarter, NKTR stock was purchased by institutional investors including:
Wealth Enhancement Advisory Services LLC
Rhumbline Advisers